AMD is a progressive disease of the retina wherein the light-sensing cone cells in the central area of vision (the macula) stop working and eventually die. The disease is thought to be caused by a combination of genetic and environmental factors, and it is most common in people who are age sixty and over.
At its worst, macular degeneration will damage only central vision, which arises from the macular area, comprising less than 5% of the total retina, but responsible for about 35% of the visual field. This means that an affected person will find it difficult or impossible to read, drive, or recognize faces. The peripheral vision, however, is left untouched. Many affected people move about with no assistance at all and, with the help of both visual and non-visual devices, many lead independent, productive lives.
This description of AMD is from the MD Support web site.7 It is typical of the descriptions found everywhere, most notably the emphasis on the fact that the peripheral field is spared by the disease and that blindness is not a result. Here are examples from four other respectable sources.
1. Macular degeneration alone does not result in total blindness. Most people continue to have some useful vision and are able to take care of themselves. (Kellogg Eye Center, University of Michigan)8
2. This disorder results in the loss of central vision only -- peripheral fields are always maintained. Although loss of ability to read and drive may be caused by macular degeneration, the disease does not lead to complete blindness. (U.S. National Library of Medicine & the National Institutes of Health) 9
3. Patients can be told that although central visual loss is common, peripheral visual loss is rare. (American Academy of Ophthalmology)10
4. ARMD never causes total blindness. Persons with ARMD, even its most severe form, have normal peripheral or side vision. If you know of someone who has ARMD and has lost peripheral vision, this is not because of ARMD but because of another eye condition. (University of Alabama Department of Ophthalmology)11
As the MD Support survey showed, most people who have had AMD for several years know that, unless a secondary condition affects their peripheral field, they will maintain a fair amount of independence and unassisted mobility. They may have defects in their visual fields (blind spots, distortion or scarring) that prohibit seeing with that part of their retinas, but personal experience and the facts of medical science assure them that AMD will not blind them. They are, instead, affected by visual impairment, also called partial sight or low vision. Their condition may even be described as central blindness or even legal blindness, which are two examples of how the word blind can be suitably qualified.
Most agencies officially recognize the difference between a blind person and a visually impaired person. The United Kingdoms Disability Rights Commission Act 1999, for example, differentiates between blindness and partially sighted. The Blind Citizens of Australia differentiates between blind and visually impaired. These distinctions, like the definitions of blind and AMD, are well-known in the eye care field and by those who provide information and support for patients. The only reason, therefore, that someone in such a position would purposefully interchange the terms would be for dramatic effect. As one organizational representative put it, A patient will get over the shock of being told she will go blind once she learns the truth. It wont hurt her physically, and its a way of getting her through our door.
If the word blind needs to be used to inspire a greater fear of AMD, then the disease must not be frightening enough in itself. That is good news for those who have it, and it happens to be true. AMD can be initially devastating, but the patient can ultimately learn that it is not something to fear. It is neither painful nor life threatening, and it can be well-managed with proper education and treatment.
Conclusion
AMD patients must continue to arm themselves with the facts in order to not be misinformed and misled. They must maintain a healthy skepticism by not accepting what they read and hear without examining the evidence and weighing the authors motivation. Equally important, they must assist in the proper education of others. In this case, that means resisting use of the clinically inaccurate term blind when describing AMD. Visually impaired may not be as dramatic, and it may require definition for those who are new to the term, but it is at least accurate. It is most certainly easier for the newly-diagnosed to live with.
The AMD community must continue to encourage contributions to research and the necessity of eye exams for everyone. It must, however, find ways to emphasize those points without resorting to fear tactics and unsupported health claims. AMD is not the leading cause of blindness in senior citizens. It is, however, the leading cause of vision loss. That is more accurate and more acceptable to the patient population. No one knows their visual capabilities better than the people who have lived for awhile with AMD. They have now had their say, and it might be to everyone elses benefit if they are heard.
References:
1 Alliance for Aging Research. Independence for older Americans: An Investment in Our Nation's Future. (Accessed Nov. 7, 2006 at www.agingresearch.org/brochures/independence/welcome.html.)
2 Rovner BW, Casten RJ, Tasman WS. Effect of depression on vision function in age-related macular degeneration. (Arch Ophthalmol. 2002;120:1041-1044.)
3 www.mdsupport.org
4 Brody BL, Gamst AC, William RA, et al. Depression, visual axis, comorbidity and disability associated with age related macular degeneration. (Ophthalmology 2001; 108 : 1893-1900)
5 Whats In a Name? (Royal National Institute for the Blind: www.rnib.org.uk/xpedio/groups/public/documents/ Visugate/public_terminog.hcsp)
6 Who Is Blind?, Kenneth Jernigan (www.haverford.edu/ods/who_is_blind.html)
7 What Is Macular Degeneration?, Dan Roberts (www.mdsupport.org/library/md_description.html)
8 www.kellogg.umich.edu
9 www.nlm.nih.gov
10 www.aao.org/aao/education/library/ppp/upload/Age-Related-Macular-Degeneration.pdf
11 www.eyes.uab.edu